CYP21A2 and congenital adrenal hyperplasia: Over 95% of CAH cases result from biallelic loss-of-function mutations in the CYP21A2 gene encoding 21-hydroxylase, which converts 17-OH-progesterone (17OH-P) and progesterone into 11-deoxycortisol and 11-deoxycorticosterone, respectively.